| Item Type | Name |
|
Academic Article
|
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
|
|
Concept
|
Etoposide
|
|
Academic Article
|
Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.
|
|
Academic Article
|
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
|
|
Academic Article
|
Results of MIME salvage regimen for recurrent or refractory lymphoma.
|
|
Academic Article
|
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.
|
|
Academic Article
|
Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.
|
|
Academic Article
|
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
|
|
Academic Article
|
Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma.
|
|
Academic Article
|
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
|
|
Academic Article
|
MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.
|
|
Academic Article
|
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
|
|
Academic Article
|
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
|
|
Academic Article
|
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
|
|
Academic Article
|
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
|
|
Academic Article
|
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
|
|
Academic Article
|
Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
|
|
Academic Article
|
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience.
|
|
Academic Article
|
Results of treatment of small non-cleaved cell lymphoma in patients without positive HIV serology.
|
|
Academic Article
|
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
|
|
Academic Article
|
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
|
|
Academic Article
|
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
|
|
Academic Article
|
VIII International Conference on malignant lymphoma. June 12-15, 2002 Lugano, Switzerland.
|
|
Academic Article
|
High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphoma.
|
|
Academic Article
|
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
|
|
Academic Article
|
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
|
|
Academic Article
|
Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
|
|
Academic Article
|
Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.
|
|
Academic Article
|
Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.
|
|
Academic Article
|
Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.
|
|
Academic Article
|
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
|